Selected article for: "PDB code and SARS cov"

Author: Belhassan, Assia; Chtita, Samir; Zaki, Hanane; Lakhlifi, Tahar; Bouachrine, Mohammed
Title: Molecular docking analysis of N-substituted Oseltamivir derivatives with the SARS-CoV-2 main protease
  • Cord-id: 59wuf88m
  • Document date: 2020_5_31
  • ID: 59wuf88m
    Snippet: The identification of chemotherapeutic drugs against Novel Coronavirus (2019-nCoV) is a significant requirement due to the rapid rise in deaths due to Corona Viral Infection all around the world. Therefore, it is of interest to document the molecular docking analysis data of 32 N-substituted Oseltamivir derivatives inhibitors of influenza virus H5N1 with the Novel Coronavirus main protease (2019-nCoV). We describe the optimal binding features of Oseltamivir derivatives with the SARS-Cov-2 main p
    Document: The identification of chemotherapeutic drugs against Novel Coronavirus (2019-nCoV) is a significant requirement due to the rapid rise in deaths due to Corona Viral Infection all around the world. Therefore, it is of interest to document the molecular docking analysis data of 32 N-substituted Oseltamivir derivatives inhibitors of influenza virus H5N1 with the Novel Coronavirus main protease (2019-nCoV). We describe the optimal binding features of Oseltamivir derivatives with the SARS-Cov-2 main protease (Code PDB: 6LU7) for further consideration.

    Search related documents:
    Co phrase search for related documents
    • active site and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site dock and acute respiratory syndrome: 1
    • active site dock and acute respiratory syndrome coronavirus: 1